Intrinsiqq
Harte-Hanks Inc. logo

Harte-Hanks Inc.

HHS

Compare

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$27M
EPS-$0.65
P/E-5.54
P/FCF-2.72
EV/EBITDA-7.10
FCF Yield–
Div. Yield–
Net Debt/FCF-2.4x
Harte-Hanks Inc. intrinsic value
52-Week Range
$2.27$4.65

Profitability & Returns

Revenue (TTM)

$155M

▼ -13.9% YoY

Net Income (TTM)

-$5M

▲ +97.3% YoY

Op. Margin

-4.63%

▼ -0.9pp YoY

ROIC

-13.71%

▼ -2.8pp YoY

Cash Flow & Balance Sheet

FCF (TTM)

-$10M

▲ +33.3% YoY

Op. Cash Flow (TTM)

-$8M

▲ +41.9% YoY

Net Debt

$24M

Cash & Equiv.

$2M

5Y CAGR: -2.0%

Continue Research

Peers

Services-Direct Mail Advertising Services · Pick stocks to compare with HHS

CompareIntrinsic value
GLOOGloo Holdings, Inc.
$2.15-16.02%30
SMRTSmartRent Inc.
$1.47+2.80%41
CHRCheer Holding Inc.
$1.02-8.93%71
STEMStem, Inc.
$0.64-12.79%39
BIRDAllbirds, Inc.
$1.07-7.79%10
SSTSystem1 Inc.
$0.67-7.97%10
CLPSCLPS Inc.
$0.84-0.71%8
CMCMCheetah Mobile Inc.
$1.83-1.08%36

Harte-Hanks (HHS) in four numbers

Fair value (revenue)
$6.44
Price $3.60 is 44% below it.
Intrinsic Value
Quality score
8/100
Best check: share count change, -0.0%. Weakest: return on capital, -13.7%.
Quality
Dividend
None
Last paid in 2016, nothing since.
Dividends
P/E
-5.54
Negative: a loss over the last twelve months. Price to free cash flow -2.72.
Financials

Questions about Harte-Hanks

Is Harte-Hanks (HHS) overvalued?

At $3.60, Harte-Hanks' price is 44% below the $6.44 a share fair value that Intrinsiqq's calculator gets from its revenue. The growth behind that figure is yours to set on the Intrinsic Value tab. See how to tell if a stock is overvalued.

What is Harte-Hanks' fair value?

Intrinsiqq's calculator puts Harte-Hanks' fair value at $6.44 a share. It grows revenue per share 0% a year for 5 years, applies an exit P/S of 0.5, and works back at a 10% yearly return. A 25% margin of safety gives a buy-below price of $4.83. Every input can be changed on the Intrinsic Value tab.

Is Harte-Hanks a high-quality business?

Harte-Hanks scores 8 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 6 checks computed from SEC filings. Its best check is share count change at -0.0%, and its weakest is return on capital at -13.7%. The Quality tab shows every check against its target.

Does Harte-Hanks (HHS) pay a dividend?

No. Harte-Hanks (HHS) does not currently pay a dividend. The last payment in our data was in 2016, and nothing has been paid since. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: 10-Q filed 30 Oct 2026 (period ending 30 Sept 2026), SEC. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in HHS's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing HHS

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.